Newport Pagnell, United Kingdom

Colin MacKinnon


 

Average Co-Inventor Count = 5.3

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Colin MacKinnon: Innovator in Cancer Treatment

Introduction

Colin MacKinnon is a notable inventor based in Newport Pagnell, GB, recognized for his contributions to medical chemistry with a focus on developing compounds aimed at treating various disorders. With a portfolio of three patents, his work makes significant strides in the field of pharmaceuticals.

Latest Patents

Colin's latest patents include innovative compounds designed as S100-inhibitors. One patent describes Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives, which are useful in treating cancer, inflammatory disorders, autoimmune disorders, and neurodegenerative disorders. Another patent details N-(heteroaryl)-sulfonamide derivatives, which inhibit interactions between S100A9 and partners such as RAGE, TLR4, and EMMPRIN. These compounds present valuable therapeutic options for treating similar conditions.

Career Highlights

Colin MacKinnon is associated with Active Biotech AB, where he plays a crucial role in advancing the development of new pharmaceuticals. His commitment to research and innovation has positioned him among experts in his field, focusing on addressing pressing health challenges through his patents.

Collaborations

Throughout his career, Colin has collaborated with talented professionals, including Stephen East and Ingela Fritzson. These partnerships underscore the collaborative nature of innovation in scientific research and development.

Conclusion

Colin MacKinnon stands out as a dedicated inventor with a mission to improve patient outcomes through innovative pharmaceuticals. His latest patents illustrate the potential of S100-inhibitors in treating significant health issues, reinforcing the importance of continued research and development in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…